Semaglutide

Semaglutide is a GLP-1 receptor agonist that regulates blood sugar and reduces appetite, used for type 2 diabetes management (Ozempic, Rybelsus) and chronic weight management (Wegovy). It is highly effective, often resulting in 10-15% body weight loss, but commonly causes gastrointestinal side effects like nausea and diarrhea